Search by Drug Name or NDC
NDC 14789-0137-05 Potassium Chloride 29.8 mg/mL Details
Potassium Chloride 29.8 mg/mL
Potassium Chloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nexus Pharamaceuticals Inc.. The primary component is POTASSIUM CHLORIDE.
Product Information
| NDC | 14789-0137 |
|---|---|
| Product ID | 14789-137_dfdb8b17-8766-4d7c-a41f-242349b58ea8 |
| Associated GPIs | |
| GCN Sequence Number | 001255 |
| GCN Sequence Number Description | potassium chloride VIAL 2 MEQ/ML INTRAVEN |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 03350 |
| HICL Sequence Number | 000549 |
| HICL Sequence Number Description | POTASSIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Potassium Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 29.8 |
| Active Ingredient Units | mg/mL |
| Substance Name | POTASSIUM CHLORIDE |
| Labeler Name | Nexus Pharamaceuticals Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217704 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 14789-0137-05 (14789013705)
| NDC Package Code | 14789-137-05 |
|---|---|
| Billing NDC | 14789013705 |
| Package | 25 VIAL, GLASS in 1 CARTON (14789-137-05) / 20 mL in 1 VIAL, GLASS (14789-137-07) |
| Marketing Start Date | 2023-09-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |